ZAK-43
87 items |
— ZA 43844 — 2025-11-17 — Injectable
Huge disparities in PrEP uptake across Europe – injectable PrEP largely inaccessible
— ZA 43652 — 2025-07-17 — Injectable
Most Patients With HIV Opted for Injectable ART, PrEP in Phase 3 Trial
— ZA 43683 — 2025-07-07 — Injectable
Cambodia 2nd Asian country to rollout long-acting injectable HIV prevention option
— ZA 43181 — 2025-06-20 — Injectable
Injectable HIV Prevention Drug Gets FDA Nod
— ZA 42919 — 2025-03-21 — Injectable
Expanded Use of Long-Acting Injectables for HIV and HIV Prevention
— ZA 42966 — 2025-03-07 — Injectable
Long-acting injectable HIV therapy offers hope for those unable to take pills
— ZA 43045 — 2025-02-11 — Injectable
Scottish Medicines Consortium approves the uses of long-lasting, injectable PrEP
— ZA 42567 — 2024-12-31 — Injectable
Injectable ARVs: The new technology in the fight against HIV and AIDS
— ZA 42576 — 2024-12-26 — Injectable
Anticipated facilitators and barriers for long-acting injectable antiretrovirals as HIV treatment ...
— ZA 42762 — 2024-10-31 — Injectable
Zambia launches injectable HIV prevention drug
— ZA 42784 — 2024-10-25 — Injectable
Six firms get licence to make crucial HIV injectable
— ZA 42798 — 2024-10-23 — Injectable
Long-Acting Injectable HIV Therapy: Addressing Adherence Challenges
— ZA 42488 — 2024-07-17 — Injectable
The big switch to injectable HIV treatment
— ZA 41780 — 2024-06-26 — Injectable
HIV trial shows injectable prevents 100% infection in women and girls
— ZA 41832 — 2024-06-13 — Injectable
Long-Acting Injectable Antiretroviral Therapy Less Appealing to Marginalized Communities
— ZA 42056 — 2024-04-23 — Injectable
Real-world use of long-acting cabotegravir and rilpivirine: 12-month results of the inJectable ...
— ZA 41426 — 2024-03-19 — Injectable
Long-acting injectable CAB/RPV superior to oral ART in nonadherent HIV-infected individuals
— ZA 41529 — 2024-02-23 — Injectable
ViiV Healthcare reports data from injectable HIV treatment trial
— ZA 41539 — 2024-02-22 — Injectable
GSK's injectable HIV drug shows promise over daily pills
— ZA 41567 — 2024-02-15 — Injectable
Injectable HIV-prevention Drug Launches in Zambia
— ZA 41117 — 2023-11-17 — Injectable
New injectable drugs give hope to HIV fight
— ZA 41134 — 2023-11-15 — Injectable
Injectable HIV drug less accessible to patients in B.C
— ZA 41281 — 2023-10-18 — Injectable
First long-acting injectable HIV PrEP on PBS
— ZA 40562 — 2023-08-31 — Injectable
Panel's endorsement paves the way for insurance coverage of injectable PrEP
— ZA 40636 — 2023-08-18 — Injectable
Injectable PrEP requires new testing procedures, IAS conference hears
— ZA 40186 — 2023-05-19 — Injectable
Injectable HIV-prevention drug to be made in South Africa for the first time
— ZA 39857 — 2023-03-22 — Injectable
AIDS Vancouver launches campaign to have injectable HIV treatment covered in B.C.
— ZA 39844 — 2023-03-21 — Injectable
AIDS Vancouver wants B.C. to cover injectable HIV treatment
— ZA 39787 — 2023-03-09 — Injectable
New Research Shows Long-Acting Injectable is Preferable to Pills
— ZA 39660 — 2023-02-15 — Injectable
Long-Acting Injectable Preferred for HIV Preexposure Prophylaxis
— ZA 39573 — 2023-01-27 — Injectable
Extended trial data show injectable HIV regimen effective when given every 2 months
— ZA 37634 — 2022-12-23 — Injectable
Injectable HIV treatment offers hope to Ugandan patients
— ZA 37652 — 2022-12-21 — Injectable
Long-acting injectable PrEP is a big step forward in HIV prevention
— ZA 37688 — 2022-12-13 — Injectable
HIV/AIDS injectable treatment drug
— ZA 37888 — 2022-11-10 — Injectable
Govt approves new HIV injectable drug
— ZA 37908 — 2022-11-08 — Injectable
South Africa to begin piloting injectable PrEP in early 2023
— ZA 38357 — 2022-08-26 — Injectable
Advocates call on ViiV to lower price of long-acting HIV injectable
— ZA 38510 — 2022-08-03 — Injectable
Injectable HIV Prevention Better Than Pills in Two Trials
— ZA 38624 — 2022-07-13 — Injectable
GSK launches Vocabria and Rekambys – a long-term injectable treatment for HIV
— ZA 38863 — 2022-05-18 — Injectable
Gilead Sciences' Can Resume Injectable Lenacapavir Trial(s) For HIV Infection
— ZA 38871 — 2022-05-17 — Injectable
Kenya: HIV positive patients hopeful after trials for injectable drugs begin
— ZA 38923 — 2022-05-04 — Injectable
Label Changes for Cabenuva, the Long-acting, Injectable HIV Treatment
— ZA 39076 — 2022-03-31 — Injectable
FDA approves long-acting injectable HIV regimen for adolescents
— ZA 39110 — 2022-03-23 — Injectable
UN to roll out injectable PrEP in South Africa
— ZA 39304 — 2022-02-04 — Injectable
First injectable for HIV prevention isn't cost-effective
— ZA 39429 — 2022-01-07 — Injectable
Hope as FDA approves injectable for HIV prevention
— ZA 34248 — 2021-12-30 — Injectable
FDA approves new injectable PrEP option for HIV prevention, health experts say adherence is key
— ZA 34274 — 2021-12-24 — Injectable
Long-acting injectable for HIV approved for use in the UK
— ZA 34277 — 2021-12-24 — Injectable
US approves first injectable drug to prevent HIV infection
— ZA 34284 — 2021-12-23 — Injectable
FDA approves first injectable PrEP medication to lower HIV risk
— ZA 34285 — 2021-12-23 — Injectable
First Long-Acting Injectable Approved for HIV PrEP
— ZA 34190 — 2021-12-22 — Injectable
FDA Approves First Injectable HIV Prevention Drug
— ZA 34192 — 2021-12-21 — Injectable
FDA Approves Apretude, Long-acting Injectable Option For HIV Prevention ...
— ZA 34604 — 2021-10-05 — Injectable
Long-Acting Injectable PrEP for HIV Risk
— ZA 34667 — 2021-09-21 — Injectable
LA Injectables, Short CM Treatment, and Implications for Africa
— ZA 34798 — 2021-08-25 — Injectable
CUNY SPH and NYC Health Department receive grant to study long-acting injectables for HIV
— ZA 35359 — 2021-04-22 — Injectable
The potential role of long-acting injectable cabotegravir–rilpivirine in the treatment of HIV in sub ...
— ZA 35755 — 2021-01-29 — Injectable
Injectable PrEP could be 'discreet' HIV prevention option for women
— ZA 35762 — 2021-01-28 — Injectable
Long-acting injectable cabotegravir prevents HIV infection in women
— ZA 36069 — 2020-11-24 — Injectable
Injectable PrEP more popular than pills among sexually active teens to prevent HIV
— ZA 36101 — 2020-11-17 — Injectable
PrEP injectable is a game-changer in the battle against HIV/Aids
— ZA 36107 — 2020-11-13 — Injectable
HIV prevention to shift from oral pills to injectables
— ZA 36110 — 2020-11-13 — Injectable
Providers Can Successfully Administer Monthly Injectable HIV Treatment
— ZA 36121 — 2020-11-11 — Injectable
Study finds long-acting injectable HIV prevention option is effective for cisgender women
— ZA 36176 — 2020-10-29 — Injectable
Patients Stay on Track With Injectable HIV Tx During Pandemic
— ZA 36229 — 2020-10-19 — Injectable
EU regulator greenlights first injectable HIV drug
— ZA 36931 — 2020-05-21 — Injectable
Study finds long-acting injectable HIV prevention option is effect
— ZA 37256 — 2020-03-12 — Injectable
Every-Other-Month Injectable HIV Treatment Works
— ZA 37258 — 2020-03-12 — Injectable
Injectable HIV regimen demonstrates similar efficacy when administered monthly, bimonthly
— ZA 37501 — 2020-01-21 — Injectable
Specialty Injectable Generics In-depth Study on Analysis and Forecast 2019-2026
— ZA 33685 — 2019-09-24 — Injectable
Long-Acting Injectable Multi-Drug Implant Shows Promise for HIV Prevention and Treatment
— ZA 33650 — 2019-09-17 — Injectable
Showcasing a monthly injectable HIV treatment
— ZA 33297 — 2019-07-12 — Injectable
ViiV launches trial to implement monthly injectable HIV therapy
— ZA 33110 — 2019-06-06 — Injectable
São Paulo Seeks Volunteers for new Anti-HIV Injectable Drug
— ZA 32068 — 2018-11-27 — Injectable
Injectable antiretroviral drugs welcome move for Uganda
— ZA 32046 — 2018-11-22 — Injectable
Uganda begins clinical trial of injectable antiretroviral (HIV) drug
— ZA 31807 — 2018-10-10 — Injectable
Long-Acting Injectable Implant Shows Promise for HIV Treatment and Prevention
— ZA 30614 — 2018-02-23 — Injectable
HIV Risk Among Injectable Drug Users Impacted by Diversity
— ZA 28657 — 2017-04-11 — Injectable
Injectable Implant May be the Future of HIV Prevention
— ZA 28020 — 2016-12-28 — Injectable
First human trials of long-acting injectable drug to prevent HIV underway
— ZA 27980 — 2016-12-21 — Injectable
First large-scale clinical study of long-acting injectable HIV drug begins
— ZA 25851 — 2016-01-12 — Injectable
HIV cure update: ViiV and Janssen to start clinical testing for injectable HIV treatment
— ZA 23121 — 2015-03-18 — Injectable
Risk of HIV Infection Increases With an Injectable Hormonal Contraceptive
— ZA 22678 — 2015-01-30 — Injectable
Injectables Increase HIV Risk?
— ZA 22475 — 2015-01-09 — Injectable
Study supports link between injectable hormonal contraceptive and HIV risk
— ZA 19207 — 2014-03-05 — Injectable
Study comparing injectable contraceptives DMPA and NET-EN finds HIV risk higher with DMPA
— ZA 12128 — 2012-12-27 — Injectable
Resistance to injectable second-line drugs in TB related to age, HIV status